Skip to main content

Phase 3 Open-Label Stdy to Eval Switch Opt Stable Antiretro Reg Cont Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Infectious Diseases

Awarded By

Gilead Sciences, Inc.

Start Date

December 1, 2013

End Date

September 18, 2017
 

Administered By

Medicine, Infectious Diseases

Awarded By

Gilead Sciences, Inc.

Start Date

December 1, 2013

End Date

September 18, 2017